Latest News - Biotech - United States - District Of Columbia

HillCo Health, based in Washington DC, is a strategic B2G full-service health policy consulting firm that advises bio-pharmaceutical, medical device, and healthcare companies on federal and state coverage, coding, and payment matters.

Legislative enacted drug and device reimbursement reforms, and the growing influence of the estimated $1 Trillion government-run healthcare systems, will impact reimbursement for oncology medicines and technologies as well as royalty agreements.

HillCo Health, based in Washington DC, is a strategic B2G full-service health policy consulting firm that advises bio-pharmaceutical, medical device, and healthcare companies on federal and state coverage, coding, and payment matters.

Saluting Black Women in Business: Yesterday, Today, and Tomorrow The Congressional Black Caucus Foundation Recognizes Boeing Director, Joan Robinson-Berry, as Executive Leader during Annual Legislative Conference

Millions of uninsured and financially-struggling Americans are depending on us to accomplish comprehensive health care reform this year. America’s pharmaceutical companies are signaling their strong support for these critically important efforts.

Emergency Preparedness Leaders, Health and School Officials, Business, Public and Private sector Partners will have access to H1N1 Flu experts around the world to discuss the possibility of a more severe outbreak of H1N1 flu this fall.

DMAA: The Care Continuum Alliance launches new Web site dedicated to the contributions of prevention, wellness and population health management to care quality and value and to promote population-based care as an essential component of system reform.

Pharmaceutical Sales Representative (College Overhire) - 2009 - United States: Johnson & Johnson Family of Companies

The five drugs that accounted for the most dispensed scrips include four generics and just one branded product--and that brand saw scrips drop

MedAssurant Inc., a premier provider of data-driven health care solutions, becomes the first Alliance Partner in program recently launched by DMAA: The Care Conitnuum Alliance to recognize population health improvement industry leaders.

DMAA: The Care Continuum Alliance says time is now to move from system of reactionary care to one focused on prevention and promotion of health as a shared national resource.

Pharma CEOs more confident than leaders of other industries

The NAPRx forecast predicts global pharmaceutical sales to surpass $820 billion in 2009, reflecting sustained double-digit growth in key emerging countries tempered by a single digit pace in more established markets.

There will be major changes in the global pharmaceutical market and key changes in the top ten company list by 2012, says a new report from industry association NAPRx, a leading provider of pharmaceutical industry business information.

Novo Nordisk joins a long list of pharmaceutical companies who have utilized the NAPRx® when they look to add to their pharmaceutical sales force. Pharmaceutical Sales (Diabetes Care Specialists) positions are available at Novo Nordisk-Apply Today.

PhRMA revises its code of conduct to ensure their medicines are marketed in a manner that benefits patients and the enhances the practices of medicine. NAPRX® adds several new compliance officers to aid in the process to comply with the new code.

At PharmaForce 2008, you will gain strategic insight into overcoming your sales strategy challenges and ensure you walk away with usable strategies to boost the ROI of your sales force while remaining compliant in this highly competitive environment.

According to the Bureau of Labor Statistics (U.S. DOL) report, “There are many federal certifications designed to raise standards and develop the skills of sales representatives."--NAPRx® - CNPR® is one of them.

The NAPRx® announces that it has reached an agreement to begin offering the (CNPR®) training program through the University of Wisconsin

The NAPRx® announces that it has reached an agreement to begin offering the (CNPR®) training program through the University of Wisconsin

Strategic BioSciences and Sinol USA announced today their intent to enter into a definitive agreement to develop and market a new formulation of SINOL Nasal Sprays with MucoAd™, a patented liquid mucoadhesive carrier.

Strategic Pharmaceutical Advisors (SRxA), a leading U.S. healthcare strategic marketing consulting and education firm proudly announced the formation of its European affiliate Strategic Respiratory Advisors – Europe (SRxA–Europe).

Strategic Pharmaceutical Advisors (SRxA) proudly announces the addition of M. Jennifer Derebery, MD as Vice President of Strategic Ear, Nose & Throat Advisors (SENTA), a SRxA affiliated company.